Safety and Tolerability of hRPC in Retinitis Pigmentosa
Estado: Reclutando |
Categoría: Retinosis pigmentaria |
Resultado: No tiene datos
RETINOSIS PIGMENTARIA
Drug: hRPC
Retinal Research Institute, Phoenix, Arizona, United States
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
Oregon Health and Science University, Portland, Oregon, United States
Institut de la M cula, Barcelona, Spain
Oxford Eye Hospital, Oxford, United Kingdom
Ver informe